271 related articles for article (PubMed ID: 17027025)
1. Ranolazine decreases diastolic calcium accumulation caused by ATX-II or ischemia in rat hearts.
Fraser H; Belardinelli L; Wang L; Light PE; McVeigh JJ; Clanachan AS
J Mol Cell Cardiol; 2006 Dec; 41(6):1031-8. PubMed ID: 17027025
[TBL] [Abstract][Full Text] [Related]
2. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts--role of late sodium current and intracellular ion accumulation.
Sossalla S; Wagner S; Rasenack EC; Ruff H; Weber SL; Schöndube FA; Tirilomis T; Tenderich G; Hasenfuss G; Belardinelli L; Maier LS
J Mol Cell Cardiol; 2008 Jul; 45(1):32-43. PubMed ID: 18439620
[TBL] [Abstract][Full Text] [Related]
3. Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel.
Hale SL; Leeka JA; Kloner RA
J Pharmacol Exp Ther; 2006 Jul; 318(1):418-23. PubMed ID: 16617168
[TBL] [Abstract][Full Text] [Related]
4. Ranolazine antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heart.
Wasserstrom JA; Sharma R; O'Toole MJ; Zheng J; Kelly JE; Shryock J; Belardinelli L; Aistrup GL
J Pharmacol Exp Ther; 2009 Nov; 331(2):382-91. PubMed ID: 19675298
[TBL] [Abstract][Full Text] [Related]
5. A comparison between ranolazine and CVT-4325, a novel inhibitor of fatty acid oxidation, on cardiac metabolism and left ventricular function in rat isolated perfused heart during ischemia and reperfusion.
Wang P; Fraser H; Lloyd SG; McVeigh JJ; Belardinelli L; Chatham JC
J Pharmacol Exp Ther; 2007 Apr; 321(1):213-20. PubMed ID: 17202401
[TBL] [Abstract][Full Text] [Related]
6. Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit.
Hale SL; Kloner RA
J Cardiovasc Pharmacol Ther; 2006 Dec; 11(4):249-55. PubMed ID: 17220471
[TBL] [Abstract][Full Text] [Related]
7. Late sodium current inhibition alone with ranolazine is sufficient to reduce ischemia- and cardiac glycoside-induced calcium overload and contractile dysfunction mediated by reverse-mode sodium/calcium exchange.
Soliman D; Wang L; Hamming KS; Yang W; Fatehi M; Carter CC; Clanachan AS; Light PE
J Pharmacol Exp Ther; 2012 Nov; 343(2):325-32. PubMed ID: 22879384
[TBL] [Abstract][Full Text] [Related]
8. The late Na+ current (INa) inhibitor ranolazine attenuates effects of palmitoyl-L-carnitine to increase late INa and cause ventricular diastolic dysfunction.
Wu Y; Song Y; Belardinelli L; Shryock JC
J Pharmacol Exp Ther; 2009 Aug; 330(2):550-7. PubMed ID: 19403851
[TBL] [Abstract][Full Text] [Related]
9. H(2)O(2)-induced left ventricular dysfunction in isolated working rat hearts is independent of calcium accumulation.
Wang L; Lopaschuk GD; Clanachan AS
J Mol Cell Cardiol; 2008 Dec; 45(6):787-95. PubMed ID: 18817782
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection by GSK-3 inhibition: role of enhanced glycogen synthesis and attenuation of calcium overload.
Omar MA; Wang L; Clanachan AS
Cardiovasc Res; 2010 Jun; 86(3):478-86. PubMed ID: 20053658
[TBL] [Abstract][Full Text] [Related]
11. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction.
Song Y; Shryock JC; Wagner S; Maier LS; Belardinelli L
J Pharmacol Exp Ther; 2006 Jul; 318(1):214-22. PubMed ID: 16565163
[TBL] [Abstract][Full Text] [Related]
12. A selective inhibitor of Na+/Ca2+ exchanger, SEA0400, preserves cardiac function and high-energy phosphates against ischemia/reperfusion injury.
Feng NC; Satoh H; Urushida T; Katoh H; Terada H; Watanabe Y; Hayashi H
J Cardiovasc Pharmacol; 2006 Feb; 47(2):263-70. PubMed ID: 16495765
[TBL] [Abstract][Full Text] [Related]
13. Cardioprotective effect of MCC-135 is associated with inhibition of Ca2+ overload in ischemic/reperfused hearts.
Satoh N; Kitada Y
Eur J Pharmacol; 2004 Sep; 499(1-2):179-87. PubMed ID: 15363965
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial role in ischemia-reperfusion of rat hearts exposed to high-K+ cardioplegia and clonazepam: energetic and contractile consequences.
Consolini AE; Ragone MI; Conforti P; Volonté MG
Can J Physiol Pharmacol; 2007 May; 85(5):483-96. PubMed ID: 17632582
[TBL] [Abstract][Full Text] [Related]
15. 18β-Glycyrrhetinic Acid Improves Cardiac Diastolic Function by Attenuating Intracellular Calcium Overload.
Han J; Su GH; Wang YH; Lu YX; Zhao HL; Shuai XX
Curr Med Sci; 2020 Aug; 40(4):654-661. PubMed ID: 32862375
[TBL] [Abstract][Full Text] [Related]
16. Sinus node dysfunction in ATX-II-induced in-vitro murine model of long QT3 syndrome and rescue effect of ranolazine.
Wu J; Cheng L; Lammers WJ; Wu L; Wang X; Shryock JC; Belardinelli L; Lei M
Prog Biophys Mol Biol; 2008; 98(2-3):198-207. PubMed ID: 19351514
[TBL] [Abstract][Full Text] [Related]
17. Sophocarpine attenuates the Na(+)-dependent Ca2(+) overload induced by Anemonia sulcata toxin-increased late sodium current in rabbit ventricular myocytes.
Zhang S; Ma JH; Zhang PH; Luo AT; Ren ZQ; Kong LH
J Cardiovasc Pharmacol; 2012 Oct; 60(4):357-66. PubMed ID: 23064241
[TBL] [Abstract][Full Text] [Related]
18. An increase in late sodium current potentiates the proarrhythmic activities of low-risk QT-prolonging drugs in female rabbit hearts.
Wu L; Shryock JC; Song Y; Belardinelli L
J Pharmacol Exp Ther; 2006 Feb; 316(2):718-26. PubMed ID: 16234410
[TBL] [Abstract][Full Text] [Related]
19. Ranolazine as a cardioplegia additive improves recovery of diastolic function in isolated rat hearts.
Hwang H; Arcidi JM; Hale SL; Simkhovich BZ; Belardinelli L; Dhalla AK; Shryock JC; Kloner RA
Circulation; 2009 Sep; 120(11 Suppl):S16-21. PubMed ID: 19752362
[TBL] [Abstract][Full Text] [Related]
20. Ventricular function and calcium handling during ischemia.
Amende I; Bentivegna L; Morgan JP
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S42. PubMed ID: 1282612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
